Similar to our results, CLDN9 (Claudin- 9) has also been identified as a glycolysis-related gene with both risk factors and independent prognostic factors in endometrial cancer and is significantly related to the prognosis of patients (17). This evidence concerns the gene CLDN9 and endometrial cancer.